Literature DB >> 27158392

IL-13 induces the expression of 11βHSD2 in IL-13Rα2 dependent manner and promotes the malignancy of colorectal cancer.

Li Jiang1, Qi Cheng2, Binhao Zhang2, Mingzhi Zhang3.   

Abstract

Previous studies had demonstrated that IL-13 and its receptor IL-13Rα2 participated in the process of onset and development of colorectal cancer, however, its detailed mechanism was still unclear. Herein, we demonstrated that IL-13 induced the expression of 11βHSD2 in an IL-13Rα2 dependent manner in colorectal cancer cells. Furthermore, we indicated 11βHSD2 was critical for IL-13 to induce the expression of COX2 and activated Akt, which was essential for IL-13 to promote the colony formation abilities and migration abilities of colorectal cancer cells. Inhibitor of 11βHSD2 glycyrrhizic acid (GA) significantly reduced the liver metastasis of colorectal cancers cells seeded in the Appendix serous of the nude mice. These results provide evidences to reveal the molecular mechanism in the process of colorectal cancer involving IL-13 and its receptor IL-13Rα2, and may provide new therapeutic target for treatment of colorectal cancer.

Entities:  

Keywords:  11βHSD2; IL-13; IL-13Rα2; colorectal cancer

Year:  2016        PMID: 27158392      PMCID: PMC4846949     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  26 in total

1.  IL-13-induced changes in endogenous glucocorticoid metabolism in the lung regulate the proasthmatic response.

Authors:  Maureen B Josephson; Junfang Jiao; Shuyun Xu; Aihua Hu; Chinmay Paranjape; Judith S Grunstein; Yael Grumbach; Gustavo Nino; Portia A Kreiger; Joseph McDonough; Michael M Grunstein
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-06       Impact factor: 5.464

Review 2.  T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production.

Authors:  Jinfang Zhu
Journal:  Cytokine       Date:  2015-06-01       Impact factor: 3.861

3.  The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway.

Authors:  K Kawakami; J Taguchi; T Murata; R K Puri
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

4.  High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis.

Authors:  Rodrigo Barderas; Rubén A Bartolomé; María Jesús Fernandez-Aceñero; Sofia Torres; J Ignacio Casal
Journal:  Cancer Res       Date:  2012-04-13       Impact factor: 12.701

5.  Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells.

Authors:  Shuji Sai; Yuichi Nakagawa; Rie Yamaguchi; Masako Suzuki; Kimiyoshi Sakaguchi; Shuichi Okada; Jonathan R Seckl; Takehiko Ohzeki; Karen E Chapman
Journal:  Leuk Res       Date:  2011-07-26       Impact factor: 3.156

6.  Expression of the 11beta-hydroxysteroid dehydrogenase type II enzyme in breast tumors and modulation of activity and cell growth in PMC42 cells.

Authors:  K Koyama; K Myles; R Smith; Z Krozowski
Journal:  J Steroid Biochem Mol Biol       Date:  2001 Jan-Mar       Impact factor: 4.292

Review 7.  Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13.

Authors:  Miranda A Hallett; Katherine T Venmar; Barbara Fingleton
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

8.  IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis.

Authors:  Stefan Fichtner-Feigl; Cheryl A Young; Atsushi Kitani; Edward K Geissler; Hans-Jürgen Schlitt; Warren Strober
Journal:  Gastroenterology       Date:  2008-09-11       Impact factor: 22.682

Review 9.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

10.  Infiltration of alternatively activated macrophages in cancer tissue is associated with MDSC and Th2 polarization in patients with esophageal cancer.

Authors:  Jingjing Gao; Yumin Wu; Zhaoliang Su; Prince Amoah Barnie; Zhijun Jiao; Qingli Bie; Liwei Lu; Shengjun Wang; Huaxi Xu
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

View more
  8 in total

1.  Type-2 11β-hydroxysteroid dehydrogenase promotes the metastasis of colorectal cancer via the Fgfbp1-AKT pathway.

Authors:  Jin Chen; Qiu-Meng Liu; Peng-Chen Du; Deng Ning; Jie Mo; Hai-Dan Zhu; Chao Wang; Qian-Yun Ge; Qi Cheng; Xue-Wu Zhang; Ya-Wei Fan; Hui-Fang Liang; Liang Chu; Xiao-Ping Chen; Bi-Xiang Zhang; Li Jiang
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

2.  Tumour microenvironment and heterotypic interactions in pancreatic cancer.

Authors:  Raúl Muñoz Velasco; Ana García García; Paula Jiménez Sánchez; Inmaculada Montanuy Sellart; Víctor Javier Sánchez-Arévalo Lobo
Journal:  J Physiol Biochem       Date:  2022-02-01       Impact factor: 4.158

3.  Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency.

Authors:  Gretchen L Bentz; Angela J Lowrey; Dustin C Horne; Vy Nguyen; Austin R Satterfield; Tabithia D Ross; Abigail E Harrod; Olga N Uchakina; Robert J McKallip
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

4.  Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells in vitro and in vivo.

Authors:  Le Xiong; Xiao-Min Lin; Jun-Hua Nie; Hai-Shan Ye; Jia Liu
Journal:  Nanotheranostics       Date:  2021-01-01

Review 5.  Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer.

Authors:  Xujun Song; Benno Traub; Jingwei Shi; Marko Kornmann
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

Review 6.  Not Only Immune Escape-The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis.

Authors:  Iwona Kwiatkowska; Justyna Magdalena Hermanowicz; Alicja Przybyszewska-Podstawka; Dariusz Pawlak
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

Review 7.  Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review.

Authors:  Martin Braddock; Nicola A Hanania; Amir Sharafkhaneh; Gene Colice; Mats Carlsson
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

8.  Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma.

Authors:  Alexander Chehrazi-Raffle; Luis Meza; Marice Alcantara; Nazli Dizman; Paulo Bergerot; Nicholas Salgia; JoAnn Hsu; Nora Ruel; Sabrina Salgia; Jasnoor Malhotra; Ewa Karczewska; Marcin Kortylewski; Sumanta Pal
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.